Uncommon case of chronic myeloid leukemia with multiple myeloma

International Journal of Hematology

Volumn 91, Issue 4, 2010, Pages 699-704

  Ide, Masaru ^a,b   Kuwahara, Nobuo ^a   Matsuishi, Eijo ^a   Kimura, Shinya ^b   Gondo, Hisashi ^a  

^a Saga Prefectural Hospital Koseikan   (Japan)

^b SAGA UNIVERSITY   (Japan)

Author keywords

Chronic myeloid leukemia; Imatinib mesylate; Multiple myeloma; Pluripotent hematopoietic stem cel

Indexed keywords

IMATINIB; IMMUNOGLOBULIN G; IMMUNOGLOBULIN KAPPA CHAIN; PARAPROTEIN;

AGED; ANEMIA; ARTICLE; BONE LESION; BONE MARROW; CASE REPORT; CHROMOSOME; CHRONIC DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERCALCEMIA; KIDNEY FAILURE; MAINTENANCE THERAPY; MULTIPLE MYELOMA; PH; PHILADELPHIA 1 CHROMOSOME; PLASMACYTOSIS; THROMBOCYTOPENIA; TREATMENT RESPONSE; UNITED STATES;

AGED; ANTINEOPLASTIC AGENTS; BONE MARROW; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MULTIPLE MYELOMA; PIPERAZINES; PYRIMIDINES;

EID: 77954540630     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-010-0546-4     Document Type: Article

References (28)

1. Wakayama T, Fujita S, Ago H. An elder patient coexisted with multiple myeloma and chronic myeloid leukemia before treatments. Med J Shimane Pref Cent Hosp. 2005;29:63-67
2. Schwarzmeier JD, Shehata M, Ackermann J, Hilgarth M, Kaufmann H, Drach J. Simultaneous occurrence of chronic myeloid leukemia and multiple myeloma: evaluation by FISH analysis and in vitro expansion of bone marrow cells. Leukemia. 2003;17:1426-1428
3. Tanaka M, Kimura R, Matsutani A, Zaitsu K, Oka Y, Oizumi K. Coexistence of chronic myelogenous leukemia and multiple myeloma. Case report and review of the literature. Acta Haematol. 1998;99:221-223
4. Boots MA, Pegrum GD. Simultaneous presentation of chronic granulocytic leukaemia and multiple myeloma. J Clin Pathol. 1982;35:364-365
5. Galanopoulos A, Papadhimitriou SI, Kritikou-Griva E, Georgiakaki M, Anagnostopoulos NI. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia. Ann Hematol. 2009;88:281-282
6. Garipidou V, Vakalopoulou S, Tziomalos K. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate. Oncologist. 2005;10:457-458
7. Yokota A, Onoda M, Uehara T, Terano T. Coexistence of chronic myelogenous leukemia and multiple myeloma. Rinsho Ketsueki. 2005;46:919.
8. Derghazarian C, Whittemore NB. Multiple myeloma superimposed on chronic myelocytic leukemia. Can Med Assoc J. 1974;110:1047-1050
9. Nakagawa M, Noto S, Kobayashi H, Hayashi M. A case of a 47- year-old man who developed chronic myelogenous leukemia after therapy for multiple myeloma. J Obihiro Kosei Gen Hosp. 2003;6:101-106
10. Nitta M, Tsuboi K, Yamashita S, Kato M, Hayami Y, Harada S, et al. Multiple myeloma preceding the development of chronic myelogenous leukemia. Int J Hematol. 1999;69:170-173
11. Klenn PJ, Hyun BH, Lee YH, Zheng WY. Multiple myeloma and chronic myelogenous leukemia-a case report with literature review. Yonsei Med J. 1993;34:293-300.
12. MacSween JM, Langley GR. Light-chain disease (hypogammaglobulinemia and Bence Jones proteinuria) and sideroblastic anemia-preleukemic chronic granulocytic leukemia. Can Med Assoc J. 1972;106:995-998
13. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749-757
14. Standen GR, Jasani B, Wagstaff M, Wardrop CA. Chronic neutrophilic leukemia and multiple myeloma. An association with lambda light chain expression. Cancer. 1990;66:162-166
15. Lewis MJ, Oelbaum MH, Coleman M, Allen S. An association between chronic neutrophilic leukaemia and multiple myeloma with a study of cobalamin-binding proteins. Br J Haematol. 1986;63:173-180
16. Naparstek Y, Zlotnick A, Polliack A. Coexistent chronic myeloid leukemia and IgA monoclonal gammopathy: report of a case and review of the literature. Am J Med Sci. 1980;279:111-115
17. Vorobiof DA, Benjamin J, Kaplan H, Dvilansky A. Chronic granulocytic leukemia, neutrophilic type, with paraproteinemia (IgA type K). Acta Haematol. 1978;60:316-320
18. Shoenfeld Y, Berliner S, Ayalone A, Shaklai M, Djaldetti M, Pick AI, et al. Monoclonal gammopathy in patients with chronic and acute myeloid leukemia. Cancer. 1984;54:280-283
19. Ritzmann SE, Stoufflet EJ, Houston EW, Levin WC. Coexistent chronic myelocytic leukemia, monoclonal gammopathy and multiple chromosomal abnormalities. Am J Med. 1966;41:981-989
20. Maeda K, Abraham J. Polycythemia associated with myeloma. Am J Clin Pathol. 1984;82:501-505
21. Heinle EW Jr, Sarasti HO, Garcia D, Kenny JJ, Westerman MP. Polycythemia vera associated with lymphomatous diseases and myeloma. Arch Intern Med. 1966;118:351-355
22. Brody JI, Beizer LH, Schwartz S. Multiple myeloma and the myeloproliferative syndromes. Am J Med. 1964;36:315-319
23. Cobo F, Cervantes F, Martinez C, Salgado C, Blade J, Montserrat E, et al. Multiple myeloma following essential thrombocythemia. Leuk Lymphoma. 1995;20:177-179
24. Selroos O, van Assendelft A. Thrombocythaemia and multiple myeloma. A report on two cases. Acta Med Scand. 1977;201:243-247
25. Kasimis BS, Yen-Lin R, Neiman RS. Multiple myeloma associated with myelofibrosis. Report of a case and literature review. Oncology. 1981;38:369-372
26. Tzilves D, Gatopoulou A, Zervas K, Katodritou E, Patakiouta F, Tarpagos A, et al. Development of multiple myeloma in a patient with gastrointestinal stromal tumor treated with imatinib mesylate: a case report. World J Gastroenterol. 2007;13:2011-2013
27. Pandiella A, Carvajal-Vergara X, Tabera S, Mateo G, Gutiérrez N, San Miguel JF. Imatinib mesylate (STI571) inhibits multiple myeloma cell proliferation and potentiates the effect of common antimyeloma agents. Br J Haematol. 2003;123:858-868
28. Dispenzieri A, Gertz MA, Lacy MQ, Geyer SM, Greipp PR, Rajkumar SV, et al. A phase II trial of imatinib in patients with refractory/relapsed myeloma. Leuk Lymphoma. 2006;47:39-42.